logo
  

Macerich FFO Tops Estimate

Macerich Co (MAC), a real estate investment trust, on Wednesday reported fourth-quarter funds from operations of $158.8 million or $0.99 per share compared with $140.6 million or $0.94 per share last year.

Excluding items, adjusted FFO for the quarter was $1.05 per share. Analysts polled by Thomson Reuters estimated FFO of $1.03 per share for the quarter. Analysts' estimates typically exclude special items.

The company's net earnings for the quarter were $1.4 billion or $9.51 per share, and included a $8.88 per share gain on remeasurement resulting from the buyout of partner interests in five malls. This compares with earnings of $144.9 million or $1.03 per share last year.

The company's revenues for the quarter were $323 million compared with $282 million in the prior year.

Minimum rents for the quarter totaled $182.3 million compared with $155.6 million a year ago, the company said.

Analysts estimated revenues of $160.5 million for the quarter.

For the full year 2015, the company expects FFO of $3.80 to $3.90 earnings per share, while analysts expect $3.85 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment. Ontario, California-based Western Mixers Produce & Nuts, Inc. is recalling Yogurt Covered Pretzels citing Salmonella risk, according to the U.S. Food and Drug Administration. The impacted Yogurt Covered Pretzels were distributed in the State of California, through Thorp Fruit, Down Home Goods, Smart & Final, Gelson's retail stores. Novartis AG (NVS) Thursday announced that the FDA has granted Breakthrough Therapy designation to Scemblix for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia or CML in chronic phase. This is the third Breakthrough Therapy designation assigned to...

Jobless claims data was the highlight in this relatively light week for U.S. economics. In Europe, focus was on the U.K. economy where the Bank of England announced its latest policy decision and the first quarter GDP data were released. Find out the signals from the central bank and whether or not the UK economy exited a recession. In the Asia-Pacific, Australia's central bank delivered its latest policy verdict and China released trade figures.

View More Videos
RELATED NEWS
Follow RTT